Browsing by Author Lunceford, J.

Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
2019Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLCGarassino, M.; Rodriguez-Abreu, D.; Gadgeel, S.; Esteban, E.; Felip, E.; Speranza, G.; Reck, M.; Hui, R.; Boyer, M.; Cristescu, R.; Aurora-Garg, D.; Albright, A.; Loboda, A.; Kobie, J.; Lunceford, J.; Ayers, M.; Lubiniecki, G.; Piperdi, B.; Pietanza, M. C.; Garon, E.
2019KRAS mutational status and efficacy in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo plus chemo as first-line therapy for metastatic non-squamous NSCLCGadgeel, S.; Rodriguez-Abreu, D.; Felip, E.; Esteban, E.; Speranza, G.; Reck, M.; Hui, R.; Boyer, M.; Garon, E. B.; Horinouchi, H.; Cristescu, R.; Aurora-Garg, D.; Lunceford, J.; Kobie, J.; Ayers, M.; Piperdi, B.; Pietanza, M. C.; Garassino, M. C.